Skip to main content

RxNews®

Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.

Yesintek™ (ustekinumab-kfce) – New biosimilar approval

December 1, 2024 - Biocon announced the FDA approval of Yesintek (ustekinumab-kfce), biosimilar to Janssen’s Stelara® (ustekinumab).

Download PDF

Rx navigation